Infectious diarrhea in human immunodeficiency virus

Gastroenterology Clinics of North America

Volumn 30, Issue 3, 2001, Pages 637-664

  Cohen, Jonathan ^a   West, A Brian ^b   Bini, Edmund J ^a,c  

^a Division of Gastroenterology   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALBENDAZOLE; AMPHOTERICIN B; COTRIMOXAZOLE; ETHAMBUTOL; FOSCARNET; GANCICLOVIR; ISONIAZID; ITRACONAZOLE; MEPACRINE; METRONIDAZOLE; PAROMOMYCIN; PROTEINASE INHIBITOR; PYRAZINAMIDE; PYRIMETHAMINE; RIFAMPICIN; TIABENDAZOLE;

ADENOVIRUS; ALGORITHM; BALANTIDIUM; CRYPTOSPORIDIUM; CYCLOSPORA CAYETANENSIS; CYTOMEGALOVIRUS; DIAGNOSTIC TEST; DIARRHEA; DISEASE ASSOCIATION; ENDOSCOPY; FECES ANALYSIS; HERPES SIMPLEX VIRUS; HISTOPLASMA CAPSULATUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; ISOSPORA BELLI; MICROSPORUM; MYCOBACTERIUM AVIUM; OPPORTUNISTIC INFECTION; REVIEW; TREPONEMA;

EID: 0034823140     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70203-X     Document Type: Article

References (128)

1. Chinese herbs treat protease inhibitor diarrhea
2. HIV and diarrhea in the era of HAART: 1998 New York state hospitalizations
3. Infectious diarrhea in patients with AIDS
4. Etiology and management of toxic megacolon in patients with human immunodeficiency virus infection
5. Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus
6. Results of culture form colonoscopically obtained specimens for bacteria and fungi in HIV-infected patients with diarrhea
7. Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS
8. Endoscopic approach to HIV-associated diarrhea: How far is far enough?
9. Diagnostic yield and cost-effectiveness of endoscopy in chronic human immunodeficiency virus-related diarrhea
10. Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients with chronic diarrhea
11. Outcome of AIDS-associated cytomegalovirus colitis in the era of potent antiretroviral therapy
12. Risk factors for rebleeding and mortality from acute upper gastrointestinal hemorrhage in human immunodeficiency virus infection
13. Endoscopic evaluation of chronic human immunodeficiency virus-related diarrhea: Is colonoscopy superior to flexible sigmoidoscopy?
14. Risk factors for recurrent bleeding and mortality in human immunodeficiency virus infected patients with acute lower GI hemorrhage
15. Comparison of duodenal with jejunal biopsy and aspirate in chronic human immunodeficiency virus-related diarrhea
16. Cryptosporidiosis in HIV-infected patients: Diagnostic sensitivity of stool examination, based on number of specimens submitted
17. Investigation of chronic diarrhea in acquired immunodeficiency syndrome: A prospective study of 155 patients
18. Natural history and prognosis of diarrhea of unknown cause in patients with acquired immunodeficiency syndrome (AIDS)
19. Prevalence of enteric pathogens in HIV-related diarrhea in the Midwest
20. Diagnostic yield of duodenal biopsy and aspirate in AIDS-associated diarrhea
21. A 3-year follow-up of a Brazilian AIDS patient with protracted diarrhea caused by Enterocytozoon bieneusi
22. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
23. Effect of octreotide on refractory AIDS-associated diarrhea: A prospective, multicenter clinical trial
24. Etiology and outcome of lower gastrointestinal bleeding in patients with AIDS
25. Encephalitozoon (Septata) intestinalis: Cytologic, histologic, and electron microscopic features of a systemic intestinal pathogen
26. A case of coinfection by Balantidium coli and HIV in French Guiana
27. Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire
28. Use of electron microscopy in examination of faeces and rectal and jejunal biopsy specimens
29. Investigation of seemingly pathogen-negative diarrhea in patients infected with HIV1
30. The value of barium enema and colonoscopy in patients infected with HIV
31. Non-cryptosporidial diarrhea in human immunodeficiency virus (HIV) infected patients
32. Pathologic changes in the small bowel in nine patients with diarrhea associated with a coccidia-like body
33. Examination of the prevalence and seasonal variation of intestinal microsporidiosis in the stools of persons with chronic diarrhea and human immunodeficiency virus infection
34. Modification of the clinical course of intestinal microsporidiosis in acquired immunodeficiency syndrome patients by immune status and anti-human immunodeficiency virus therapy
35. Investigating diarrhea in patients with acquired immunodeficiency syndrome
36. HIV-1 protease inhibitors: A review for clinicians
37. Diagnosis of intestinal microsporidiosis by examination of stool and duodenal aspirate with Weber's modified trichrome and Uvitex 2B strains
38. Cytomegalovirus colitis in AIDS: Presentation in 44 patients and a review of the literature
39. Cytomegalovirus appendicitis in a patient with acquired immune deficiency syndrome
40. Electron microscopy of the intestine and rectum in acquired immunodeficiency syndrome
41. Pilot study of sandostatin (octreotide) therapy of refractory HIV-associated diarrhea
42. Preliminary investigation of enteric-coated pancrealipase therapy in HIV+ patients with chronic diarrhea
43. Improvement of chronic diarrhes in patients with advanced HIV-1 infection during potent antiretroviral therapy
44. A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion
45. Diarrhea in AIDS and other immunodeficiency states
46. Diarrhea in human immunodeficiency virus antibody-positive patients
47. Gastrointestinal cytomegalovirus disease
48. Understanding intestinal spore-forming protozoa: Cryptosporidia, microsporidia, isospora, and cyclospora
49. Intestinal infection by microsporidia Enterocytozoon bieneusi in patients with AIDS: An ultrastructural study of the use of human mitochondria by a protozoan
50. Intestinal parasites in patients with diarrhea and human immunodeficiency virus infection in Zimbabwe
51. Nelfinavir-associated diarrhea is manageable with nonprescription medications
52. Parasitic diseases in immunocompromised hosts: Cryptosporidiosis, isosporiasis, and strongyloidiasis
53. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
54. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens
55. A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS
56. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome
57. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
58. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): Clinical findings, diagnosis, and treatment
59. Adenovirus colitis in the acquired immunodeficiency syndrome
60. Efficient management of diarrhea in the acquired immunodeficiency syndrome (AIDS): A medical decision analysis
61. Epidemiology and management of diarrheal disease in HIV-infected patients
62. A prospective study of endoscopy in HIV-associated diarrhea
63. Small bowel bacterial overgrowth: A cause of chronic HIV-associated pathogen-negative diarrhea
64. Declining prevalence of cryptosporidiosis in San Francisco
65. Light microscopic diagnosis of microsporidiosis in patients with AIDS
66. Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation
67. Spontaneous colonic perforation secondary to cytomegalovirus in a patient with acquired immunodeficiency syndrome
68. The pathologic spectrum of gastrointestinal and hepatic histoplasmosis
69. Impact of antiretroviral therapy (ART) on cryptosporidiosis outcome and factors of clinical resistance
70. Diarrheal diseases associated with HIV infection
71. Intestinal spirochetosis
72. Quality of life and health service use among HIV-infected patients with chronic diarrhea
73. Causes of chronic diarrhe in patients with AIDS in Thailand: A prospective clinical and microbiological study
74. Protozoal infections in patients with AIDS: Cryptosporidiosis, isosporiasis, cyclosporiasis, and microsporidiosis
75. Diagnostic strategies in HIV-infected patients with diarrhea
76. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy
77. Diagnosis and treatment of colonic disease in AIDS
78. Intussusception, adenovirus, and children: A brief reaffirmation
79. Cytomegalovirus colitis in AIDS: CT features
80. Human milk glycoconjugates that inhibit pathogens
81. Colorectal spirochetosis: Clinical significance of the infestation
82. The diagnostic value of electron microscopy in human immunodeficiency virus-positive patients with gastrointestinal disease
83. Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients: A report of 20 cases
84. Localization of infection by the microsporidian Enterocytozoon bieneusi in the gastrointestinal tract of AIDS patients with diarrhea
85. Cyclospora cayetanensis
86. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
87. Cyclospora infection in adults infected with HIV: Clinical manifestations, treatment, and prophylaxis
88. Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome
89. Recovery of the immune system with antiretroviral therapy: The end of opportunism?
90. Opportunistic protozoa in stool samples from HIV-infected patients
91. Diagnostic workup strategies for patients with HIV-related chronic diarrhea: What is the end result?
92. The role of Microsporidia in the pathogenesis of HIV-related chronic diarrhea
93. The treatment (TX) of nelfinavir (NFV) induced diarrhea
94. Intestinal infections in patients with acquired immunodeficiency syndrome: A prospective study in 132 patients
95. Efficacy of octreotide in the management of chronic diarrhea in AIDS
96. A double-blind placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhea in AIDS patients in Mexico
97. Stool viruses, coinfections, and diarrhea in HIV-infected patients
98. Cyclospora cayetanensis infection in patients with and without AIDS: Biliary disease as another clinical manifestation
99. Evaluation of diarrhea in HIV-infected patients
100. Diarrhea in patients with the acquired immunodeficiency syndrome
101. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea
102. Cytomegalovirus
103. Combination drug therapy for cryptosporidiosis in AIDS
104. Infectious diarrheas in patients with AIDS
105. Infectious diarrhea in human immunodeficiency virus infection
106. Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS): Etiology and response to therapy
107. NIH conference: Gastrointestinal infections in AIDS
108. AIDS-related cryptosporidial diarrhea: An open study with roxithromycin
109. Detection of Enterocytozoon bieneusi in fecal specimens by polymerase chain reaction analysis with primers to the small-subunit rRNA
110. Gastrointestinal manifestations
111. Cytomegalovirus vasculitis and colon perforation in a patient with the acquired immunodeficiency syndrome
112. Roxithromycin treatment for diarrhea caused by Cryptosporidium spp. in patients with AIDS
113. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients: A randomized, controlled trial
114. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors
115. Diarrheal disease in patients infected with human immunodeficiency virus in Bangkok, Thailand
116. Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus
117. Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates
118. Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole
119. Endoscopy in acquired immunodeficiency syndrome patients with diarrhea and negative stool studies
120. Cytomegalovirus colitis in acquired immunodeficiency syndrome: A clinical and endoscopic study
121. AGA technical review: Malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection
122. Chronic unexplained diarrhea in human immunodeficiency virus infection: Determination of the best diagnostic approach
123. Cytomegalovirus pseudotumor presenting as bowel obstruction in a patient with acquired immunodeficiency syndrome
124. Cyclospora: A newly identified intestinal pathogen of humans
125. Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals
126. Adenovirus colitis in human immunodeficiency virus infection: An underdiagnosed entity
127. Adenovirus and ileocecal intussusception